Cargando…

Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study

AIM: To investigate the relationship between selective serotonin reuptake inhibitor (SSRI) use and the subsequent development of irritable bowel syndrome (IBS). METHODS: This retrospective, observational, population-based cohort study collected data from Taiwan’s National Health Insurance Research D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wan-Tzu, Liao, Yi-Jun, Peng, Yen-Chun, Chang, Chung-Hsin, Lin, Ching-Heng, Yeh, Hong-Zen, Chang, Chi-Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442087/ https://www.ncbi.nlm.nih.gov/pubmed/28596687 http://dx.doi.org/10.3748/wjg.v23.i19.3513

Ejemplares similares

The Association of Selective Serotonin Reuptake Inhibitors With Delirium in Critically Ill Adults: A Secondary Analysis of the Bringing to Light the Risk Factors and Incidence of Neuropsychologic Dysfunction in ICU Survivors ICU Study
por: Austin, C. Adrian, et al.
Publicado: (2022)

Predictors of healthcare-seeking behavior among Chinese patients with irritable bowel syndrome
por: Fan, Wen-Juan, et al.
Publicado: (2017)

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
por: Fang, Xiu-Cai, et al.
Publicado: (2022)

Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study
por: Yang, Qian, et al.
Publicado: (2022)

Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study
por: Meng, Qiao, et al.
Publicado: (2021)

Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology
por: Wang, Ruo-Hui, et al.
Publicado: (2023)

Psychological Features in the Inflammatory Bowel Disease–Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors
por: Petrik, Megan, et al.
Publicado: (2021)

Serotonin receptor modulators in the treatment of irritable bowel syndrome
por: Fayyaz, Mohammad, et al.
Publicado: (2008)

Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome
por: Jin, Duo-Chen, et al.
Publicado: (2016)

Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome
por: Sabaté, Jean-Marc, et al.
Publicado: (2022)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Case–Control Study Investigating the Association Between Use of Selective Serotonin Reuptake Inhibitors and Pulmonary Tuberculosis in Taiwan
por: Cheng, Kao-Chi, et al.
Publicado: (2019)

Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome
por: Zhang, Yu, et al.
Publicado: (2019)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma
por: Lai, Shih-Wei, et al.
Publicado: (2017)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

A Case With Vitamin D Deficiency-Induced Cytomegalovirus Enteritis Presenting as Bowel Pseudo-Obstruction
por: Lee, Shou-Wu, et al.
Publicado: (2017)

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome
por: Spiller, Robin, et al.
Publicado: (2012)

Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients
por: Zhao, Shi-Rui, et al.
Publicado: (2019)

Epigenetic Mechanisms in Irritable Bowel Syndrome
por: Mahurkar-Joshi, Swapna, et al.
Publicado: (2020)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study
por: Chu, Che-Sheng, et al.
Publicado: (2016)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

The Impact of Admission Diagnosis on Recurrent or Frequent Hospitalizations in 3 Dementia Subtypes: A Hospital-Based Cohort in Taiwan with 4 Years Longitudinal Follow-Ups
por: Chang, Chiung-Chih, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients
por: Chang, Chia-Ming, et al.
Publicado: (2017)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study
por: Lagerberg, Tyra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n32ovoahskkhp3s6okinmsiird